Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Invasive Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Invasive Malignant Neoplasm
Invasive Carcinoma

Histology

Invasive Carcinoma

CI-CAN-00001040Explore in graph →

603 active trials9 approved drugs37 evidence items

NCIt: C9480

Overview
Statistics
Survival
Genomics65
Variants & evidence37
Drugs22
Trials1812
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

1,812 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 603
Recruiting: 301
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

StatusAll Active (any)Completed 659 Recruiting 354 Active Not Recruiting 259 Terminated 214 Unknown 158 Withdrawn 78 Not Yet Recruiting 71 Suspended 10 No Longer Available 4 Approved For Marketing 2 Enrolling By Invitation 2 Available 1

PhaseAll Early Phase 1 43 N/A 276 Phase 1 461 Phase 2 778 Phase 3 180 Phase 4 19

No study matches these filters